The F-MACHOP regimen in advanced diffuse aggressive lymphomas: summary of ten years' experience at a single institution

Leukemia. 1991:5 Suppl 1:102-4.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use
  • Cytarabine / administration & dosage
  • Cytarabine / therapeutic use
  • Doxorubicin / administration & dosage
  • Doxorubicin / therapeutic use
  • Fluorouracil / administration & dosage
  • Fluorouracil / therapeutic use
  • Humans
  • Leucovorin / administration & dosage
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Methotrexate / administration & dosage
  • Methotrexate / therapeutic use
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Prednisone / administration & dosage
  • Prednisone / therapeutic use
  • Vincristine / administration & dosage
  • Vincristine / therapeutic use

Substances

  • Cytarabine
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Leucovorin
  • Fluorouracil
  • Prednisone
  • Methotrexate

Supplementary concepts

  • F-MACHOP protocol